1256490-49-9

Basic information

• Product Name: (S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester
• Synonyms: N-[(R)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester;L-Alanine, N-[(R)-(4-nitrophenoxy)phenoxyphosphinyl]-, 1-methylethyl ester;(S)-2-[(R)-(4-nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester;(S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylaMino]propionic acid Isopropyl ester
• CAS NO: 1256490-49-9
• Molecular Formula: C₁₈H₂₁N₂O₇P
• Molecular Weight: 408.3477
• Mol File: 1256490-49-9.mol
• Article Data: 8

Chemical Properties

• Melting Point: 42-43℃
• Boiling Point: 514.3±60.0 °C(Predicted)
• Density: 1.302±0.06 g/cm3(Predicted)
• PKA: -5.78±0.70(Predicted)
• CAS DataBase Reference: (S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester(1256490-49-9)
• EPA Substance Registry System: (S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester(1256490-49-9)

Safety Data

• Hazardous Substances Data: 1256490-49-9(Hazardous Substances Data)

Usage

General Description

(S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester, also known as sarafotoxins s6c, is a chemical compound that is commonly used in biochemical research as a specific antagonist for endothelin receptors. It is a potent vasoconstrictor agent that has been found to have applications in the treatment of various cardiovascular diseases. Additionally, this chemical has also been studied for its potential neuroprotective properties, making it a topic of interest in the field of neuroscience. The isopropyl ester form of this compound enhances its lipophilicity, allowing for improved penetrability in lipid-rich tissues. Overall, (S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid Isopropyl ester has shown promise in various medical and research applications, particularly in the realm of cardiovascular and neurological health.

Upstream product

• 777-52-6 1-dichlorophosphoryloxy-4-nitro-benzene 
• 39825-33-7 isopropyl L-alanine 
• 108-95-2 phenol 
• 39613-92-8 alanine isopropyl ester hydrochloride 
• 770-12-7 O-phenyl phosphorodichloridate 
• 100-02-7 4-nitro-phenol 
• 793-10-2 p-nitrophenyl phenyl phosphorochloridate 
• 1256490-48-8 (S)-2-[(4-nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester 

Downstream Products

• 1190307-88-0 sofosbuvir 
• 1190308-01-0 (S)-2-{(R)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy](phenoxy)phosphorylamino}propionic acid isopropyl ester 
• 1350735-69-1 C₂₉H₃₇N₆O₉P 
• 1384122-46-6 C₂₅H₃₁N₆O₈P 

Relevant articles and documents

Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs

Nucleoside analogues are among the most common medications given for the treatment of viral infections and cancers. The therapeutic effectiveness of nucleoside analogues can be dramatically improved by phosphorylation. The ProTide approach was developed u

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

The invention provides compounds of formula (I), wherein: R1 is OR11, or NR5R5'; R2 is H or F; R5 is H, C1-C6alkyl, OH, C(=O)R6, O(C=O)R6 or O(C=O)OR6; R5′ is H or C1-C6alkyl; R6 is C1-C6alkyl or C3-C7cycloalkyl; R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects.

1'-SUBSTITUTED PYRIMIDINE N-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

Provided are compounds of Formula I: nucleosides, nucleoside phosphates and prodrugs thereof, wherein R6 is CN, ethenyl, 2-haloethen-1-yl, or (C2-C8)-alkyn-1-yl. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections.